Target intelligence / Profile preview

CD4-positive helper T lymphocyte (CD4+ T cell)

Target
CD4+ T cell
Molecular classification
Lymphocyte, T cell (a subtype of lymphocyte), Immune cell, Surface marker: CD4, Receptor-bearing cell (T cell receptor, TCR), Other: Can differentiate into subsets (Th1, Th2, Th17, Treg, Tfh, Th9, Th22) based on cytokine profile and function[1][4][6]
01

Overview

CD4-positive helper T lymphocytes are a principal subset of T cells critical for the proper functioning of the adaptive immune system[1][2][3]. They are identified by the presence of CD4 on their surface, which serves as a coreceptor for the major histocompatibility complex class II (MHC-II) on antigen-presenting cells. Upon activation, CD4+ T cells differentiate into specialized subtypes including Th1, Th2, Th17, Treg, and Tfh cells, each with distinct cytokine profiles and immune functions[4][6]. These cells orchestrate immune responses by stimulating B cells for antibody production, activating cytotoxic T cells and macrophages, and regulating inflammatory processes. CD4+ T cell depletion, especially due to HIV infection, leads to severe immunodeficiency, making their enumeration and preservation a key focus in infectious disease therapy and monitoring[2][7]. Their dysregulation is implicated in autoimmunity, cancer, and exacerbated inflammatory responses[1][4][6].

Other names
T helper lymphocyteT helper cellCD4+ T cellCD4 T lymphocyteCD4-positive T cellTh cellHelper T cell
02

Mechanism of action

Inhibition of viral entry or replication (ART drugs prevent HIV from infecting or destroying CD4+ T cells)[2] Suppression of immune function (immunosuppressants reduce T cell activation, cytokine production)[4] Modulation of cytokine signaling or subset differentiation (biologics target specific cytokines produced by T cell subsets)[4][6]

03

Biological functions

Immune response coordination and regulationActivation of other immune cells (e.g., B cells for antibody production, cytotoxic T cells, macrophages and neutrophils via cytokines)[1][2][3]Cytokine secretionB cell antibody class switchingDevelopment of immunological memory (memory T cell formation)[2]Suppression of immune response and prevention of autoimmunity (for regulatory T cells)[2][4]Formation of germinal centers and affinity maturation (for follicular helper T cells)[4]
04

Disease associations

Infection (especially HIV, which targets and destroys CD4+ T cells)[2][7]Cancer (immunosurveillance and regulatory functions)[6]Autoimmune disease (genetic variation affects susceptibility)[1][4]InflammationOther: Roles in allergic response (Th2), fungal and parasitic infection control (Th17, Th2)[2][4]
05

Safety considerations

Risk of immune suppression leading to secondary infections (when CD4+ T cells are depleted, e.g., in HIV/AIDS or after immunosuppression)[2][7]Risk of autoimmunity when regulatory T cell function is impaired[1][4]Immune reconstitution inflammatory syndrome (IRIS) after rapid restoration of CD4+ T cells in immunosuppressed patients[2]Cytokine storm or excess inflammation due to dysregulated T cell function[2][4]
06

Interacting drugs

Antiretroviral therapy (ART) drugs for HIV (e.g., zidovudine, lamivudine, efavirenz, tenofovir)[2]

2 more in the full profile.

07

Biomarkers

CD4+ T cell count (monitoring HIV progression; assessing immunodeficiency)[2][7]Surface markers for subsets (e.g., CXCR3, CD161 for Th1, CXCR5 for Tfh, CTLA-4 and CD25 for Treg)[4]Cytokine profiles depending on subset (measured in research and diagnostics)[4]

Beyond the preview

Go deeper on CD4-positive helper T lymphocyte (CD4+ T cell).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CD4-positive helper T lymphocyte (CD4+ T cell).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call